ArticleBreast cancer research : BCR2003

C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer.

Claus M Schlotter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.